Efficacy and Safety of SGLT2 Inhibitors in Reducing Glycated Hemoglobin and Weight in Emirati Patients With Type 2 Diabetes

BACKGROUND: SGLT2 inhibitors are a new class of drugs that act by inhibiting glucose reabsorption in the proximal renal tubules. Many trials have demonstrated their effectiveness in reducing glycated hemoglobin (HbA1c) and weight, but they have never been examined in Arab or Emirati populations. MET...

Descripción completa

Detalles Bibliográficos
Autores principales: Bashier, Alaaeldin, Khalifa, Azza Abdulaziz, Rashid, Fauzia, Abdelgadir, Elamin Ibrahim, Al Qaysi, Amina Adil, Ali, Razan, Eltinay, Ahmed, Nafach, Jalal, Alsayyah, Fatima, Alawadi, Fatheya
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Elmer Press 2017
Materias:
Original Article
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5412523/
https://www.ncbi.nlm.nih.gov/pubmed/28496550
http://dx.doi.org/10.14740/jocmr2976w

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5412523/
https://www.ncbi.nlm.nih.gov/pubmed/28496550
http://dx.doi.org/10.14740/jocmr2976w

Ejemplares similares